Primary cardiac rhabdomyosarcoma exhibiting transient and pronounced regression with chemotherapy.
Satoh
M
M
Division of Cardiology, National Sapporo Hospital, Japan.
Horimoto
M
M
Sakurai
K
K
Funayama
N
N
Igarashi
K
K
Yamashiro
K
K
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D005260:Female; D006338:Heart Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology; D012074:Remission Induction; D012208:Rhabdomyosarcoma / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage
D003609:Dactinomycin; D014750:Vincristine; D003520:Cyclophosphamide